Clinical benefit of eribulin (Halaven®) in the treatment of advanced soft tissue sarcoma patients and the novel anti-tumor mechanisms
| العنوان: | Clinical benefit of eribulin (Halaven®) in the treatment of advanced soft tissue sarcoma patients and the novel anti-tumor mechanisms |
|---|---|
| المؤلفون: | Hiroki Hasegawa, Osamu Tohyama, Taro Semba, Shigeru Taniguchi, Noriyuki Koyama, Kotaro Kodama |
| المصدر: | Folia Pharmacologica Japonica. 148:329-333 |
| بيانات النشر: | Japanese Pharmacological Society, 2016. |
| سنة النشر: | 2016 |
| مصطلحات موضوعية: | Pharmacology, Antitumor activity, business.industry, Soft tissue sarcoma, medicine.disease, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, chemistry, 030220 oncology & carcinogenesis, Cancer research, Medicine, business, 030217 neurology & neurosurgery, Eribulin |
| تدمد: | 1347-8397 0015-5691 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::e5d89a99a0186fa2ac1cef8b7971c01f https://doi.org/10.1254/fpj.148.329 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi...........e5d89a99a0186fa2ac1cef8b7971c01f |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 13478397 00155691 |
|---|